Suzanne George

Also affiliated with Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.789Author DataRank

Indexed papers

6in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009472

Top 32%

0.618DataRank

Top 32%16 citations

James L. Chen, Austin C Goodrich, Brian A. Van Tine, Jordan D. Campbell, Allison L. Richards +9 more

Papers

Driven by 33 papers — median percentile 0. Top paper: “Phase II study of atezolizumab in advanced alveolar soft part sarcoma (ASPS).”.

Phase II study of atezolizumab in advanced alveolar soft part sarcoma (ASPS).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11519

N/A

1.8DataRank · unranked

50 citations

Geraldine O’Sullivan Coyne, Nancy Moore, Elad Sharon, Naoko Takebe, Kristin Fino +15 more

National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3334

N/A

1.3DataRank · unranked

59 citations

James M. Ford, Peter J. O’Dwyer, Geoffrey I. Shapiro, Lisa M. McShane, Boris Freidlin +18 more

Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib

Annals of Oncology(2023)10.1016/j.annonc.2023.04.006

N/A

1.2DataRank · unranked

42 citations

Sebastian Bauer, David Gómez-Peregrina, Yoon‐Koo Kang, Robin L. Jones, Piotr Rutkowski +13 more

Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2250

N/A

0.979DataRank · unranked

35 citations

Michael J. Nathenson, Emanuele Mazzola, Jia‐Ren Lin, Joanna Bagińska, Allison Nau +11 more

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

Annals of Oncology(2020)10.1016/j.annonc.2020.08.2232

N/A

0.749DataRank · unranked

146 citations

Cristina R. Antonescu, Bodil Bjerkehagen, Judith V.M.G. Bovée, Kjetil Boye, Matías Chacón +43 more

A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009472

Top 32%

0.618DataRank

Top 32%16 citations

James L. Chen, Austin C Goodrich, Brian A. Van Tine, Jordan D. Campbell, Allison L. Richards +9 more

A multicenter phase II study of cabozantinib + nivolumab for patients (pts) with advanced angiosarcoma (AS) previously treated with a taxane (Alliance A091902).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11503

N/A

0.542DataRank · unranked

36 citations

Jacob B. Allred, Scott M. Schuetze, Elizabeth J. Davis, Michael J. Wagner, Andrew Poklepovic +10 more

Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST

British Journal of Cancer(2022)10.1038/s41416-022-01990-5

N/A

0.500DataRank · unranked

27 citations

Matthew L. Hemming, Meijun Z. Lundberg, Matthew Serrata, Isabel Goldaracena, Ninning Liu +17 more

A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3817

N/A

0.477DataRank · unranked

23 citations

Rachel S. Heise, Kristen Ganjoo, Elizabeth J. Davis, Suzanne George, Melissa Burgess +16 more

A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0640

N/A

0.416DataRank · unranked

15 citations

Michael C. Heinrich, Neeta Somaiah, Peter Oppelt, Robert McLeod, Satoshi Nishioka +11 more

Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2145

N/A

0.416DataRank · unranked

15 citations

Naoko Takebe, Shivaani Kummar, Albiruni R. Abdul Razak, Sant P. Chawla, Suzanne George +13 more

SAR-096: A phase II trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL), and leiomyosarcoma (LMS).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11544

N/A

0.396DataRank · unranked

13 citations

Margaret von Mehren, Elizabeth A. Handorf, Jeffrey A. Morgan, Michael J. Nathenson, Katherine A. Thornton +10 more

Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality

Journal of Clinical Oncology(2024)10.1200/jco.24.00347

N/A

0.208DataRank · unranked

3 citations

Bailey A. Martin-Giacalone, Bettina F. Drake, Liz Salmi, Elizabeth B. Claus, Anne L.R. Schuster +8 more

Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017

Cancer(2023)10.1002/cncr.35078

Top 67%

0.171DataRank

Top 67%2 citations

Shaylene McCue, Jun He, Jacqueline M. Lafky, Lisa A. Carey, Evanthia Galanis +9 more

Data from National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

(2023)10.1158/1078-0432.c.6533210.v1

Top 100%

0DataRank

Top 100%0 citations

James M. Ford, Peter J. O’Dwyer, Geoffrey I. Shapiro, Lisa M. McShane, Boris Freidlin +18 more

NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11506

N/A

0DataRank · unranked

11 citations

Jacob B. Allred, Katherine Gano, Suzanne George, Steven Attia, Melissa Burgess +15 more

Data from Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene Expression

(2023)10.1158/1078-0432.c.6532647.v1

N/A

0DataRank · unranked

0 citations

Patrick Bhola, Michael A. Loycano, Justin A. Anderson, Madeleine L. Taddei, Leona A. Doyle +11 more

Data from Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene Expression

(2023)10.1158/1078-0432.c.6532647

N/A

0DataRank · unranked

0 citations

Patrick Bhola, Michael A. Loycano, Justin A. Anderson, Madeleine L. Taddei, Leona A. Doyle +11 more

Data from National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

(2023)10.1158/1078-0432.c.6533210.v2

Top 100%

0DataRank

Top 100%0 citations

James M. Ford, Peter J. O’Dwyer, Geoffrey I. Shapiro, Lisa M. McShane, Boris Freidlin +18 more

Engagement of patient participation in genomics research by the Osteosarcoma and Leiomyosarcoma Count Me In Projects of the Cancer Moonshot funded PE-CGS Network.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps11588

N/A

0DataRank · unranked

0 citations

Diane M. Diehl, Carrie Cibulskis, Priscilla Merriam, Maeve Smart, Jordan Doucette +15 more

A multicenter phase II study of nivolumab +/- ipilimumab for patients with metastatic sarcoma (Alliance A091401): Results of expansion cohorts.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11511

N/A

0DataRank · unranked

50 citations

Michelle R. Mahoney, Suzanne George, Cristina R. Antonescu, David A. Liebner, Brian Andrew Van Tine +6 more

Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-20-0197

N/A

0DataRank · unranked

35 citations

Changyu Fan, Chandrajit P. Raut, George D. Demetri, Scott A. Armstrong, Ewa Sicińska +2 more

Feasibility of structuring electronic health record data to facilitate real‐world data research: ICAREdata methods applied to multicenter cancer clinical trials

Cancer(2024)10.1002/cncr.35528

N/A

0DataRank · unranked

10 citations

Nancy Campbell, Shauna L. Hillman, Elizabeth S. Harlos, David Stein, Miranda Y. Chan +14 more

Frequency and clinical features of germline pathogenic variants in sarcoma: a case-control study

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf294

N/A

0DataRank · unranked

1 citations

Miki Horiguchi, Carolyn Horton, Linda M. Polfus, Brittany Bychkovsky, Ryan M. Buehler +5 more

Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.01.20.633920

N/A

0DataRank · unranked

1 citations

Amanda Garza, Sabrina Y. Camp, Jihye Park, Samantha E. Hoffman, Laura Valderrábano +17 more

Supporting Participant Engagement in Cancer Genomics Research in Rare Cancers: A Qualitative Study of Patients, Caregivers, and Advocates

Cancer Control(2025)10.1177/10732748251364041

N/A

0DataRank · unranked

0 citations

Lily Weber, Lauren Fisher, Andrew Khalaj, Eirian Siegal-Botti, Diane M. Diehl +4 more

Data from National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

(2023)10.1158/1078-0432.c.6533210

Top 100%

0DataRank

Top 100%0 citations

James M. Ford, Peter J. O’Dwyer, Geoffrey I. Shapiro, Lisa M. McShane, Boris Freidlin +18 more

Analysis of patient (pt) withdrawal of consent using 11,993 pts from 58 alliance for clinical trials in oncology trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6513

N/A

0DataRank · unranked

0 citations

Shauna L. Hillman, Carrie Strand, David M. Zahrieh, Suzanne George, Aminah Jatoi +1 more

Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

Cancer(2021)10.1002/cncr.33618

N/A

0DataRank · unranked

229 citations

Anna Maria Frezza, Jean‐Yves Blay, Elizabeth H. Baldini, Sylvie Bonvalot, Judith V.M.G. Bovée +52 more

NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps11570

N/A

0DataRank · unranked

6 citations

Jacob B. Allred, Katherine Gano, Suzanne George, Steven Attia, Melissa Burgess +8 more

Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0998

N/A

0DataRank · unranked

12 citations

Jan Novotný, D. Gulhan, Isabella Klooster, Antuan V. Tran, Macy Kasbo +17 more

Strategies to increase accrual of underrepresented populations in Alliance NCTN trials.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6509

N/A

0DataRank · unranked

3 citations

Niveditha Subbiah, Marie Wood, Craig Steffens, Judith S. Kaur, Lucile L. Adams‐Campbell +2 more

Alliance A092104: A randomized phase 2/3 study of olaparib plus temozolomide versus investigator’s choice for the treatment of patients with advanced uterine leiomyosarcoma after progression on prior chemotherapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps11584

N/A

0DataRank · unranked

2 citations

Sumithra J. Mandrekar, Jacob B. Allred, Stephanie Berg, Martee L. Hensley, Brian Andrew Van Tine +4 more

Suzanne George

Indexed papers

Top data-sharing exemplar

Papers